Table 2.
Characteristics | Number of patients [n (%)] |
---|---|
Sex | |
Male | 7 (70) |
Female | 3 (30) |
Median age [years (range)] | 46 (19–61) |
Prior IFN therapy | 2 |
Eastern Cooperative Oncology Group performance status score | |
0 | 6 (60) |
1 | 4 (40) |
Melanoma typea | |
Cutaneous | 5 (50) |
Mucosal | 1 (10) |
Acrolentiginous | 1 (10) |
Unknown | 2 (20) |
Stagea | |
M1a | 1 (10) |
M1b | 0 |
M1c | 8 (80) |
IFN, interferon.
Data exclude one patient with a questionable diagnosis of melanoma.